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Abstract Celiac disease (CD) is a polygenic chronic
enteropathy conferring an increased risk for various nutrient
deﬁciency states. Hyperhomocysteinemia is a frequent
ﬁnding in CD and may be related to the development of
venous thrombosis, cardiovascular disease, and stroke in
untreated CD patients. Recently, a possible excess in the
frequency of the MTHFR c.677C[T (rs1801133) gene var-
iant in CD patients was reported. The purpose of this study
was to determine if there exist differences in the distribution
of polymorphic variants of genes involved in homocysteine/
methyl group metabolism between CD patients and the
general population. A set of 10 gene polymorphisms
(MTHFRrs1801133,MTRrs1805087,MTHFD1rs2236225,
MTRR rs1801394, CBS 844ins68, BHMT1 rs7356530 and
rs3733890, BHMT2 rs526264 and rs625879, and TCN2
rs1801198) was tested in 134 patients with CD and 160
matched healthy controls. The frequency of the MTR
rs1805087 GG genotype in CD patients was lower than in
controls (0.01 and 0.06, respectively), although statistical
signiﬁcance was not achieved (P = 0.06). For the other
analyzed polymorphisms, there was no evidence of differ-
enceinbothallelicandgenotypicdistributionbetweencases
and controls. The exhaustive Multifactor Dimensionality
Reduction analysis revealed no combination of interactive
polymorphismspredictingtheincidenceofCD.Incontrastto
thewell-documentedclinicalobservationsofincreasedrisks
of vascular disease in patients with longstanding untreated
CD, in our group of patients no signiﬁcant association with
CD was found for all tested polymorphic variants of genes
involved in homocysteine metabolism. These ﬁndings
should be replicated in studies with a larger sample size.
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Introduction
Celiac disease (celiac sprue, CD) is a polygenic chronic
enteropathy, resulting from an aberrant cellular response to
gluten peptides, which are storage proteins in wheat, bar-
ley, and rye. CD is one of the most common disorders
affecting humans with prevalence in populations of Cau-
casian descent close to 1:100 with the majority of patients
awaiting diagnosis [1]. The only treatment is a lifelong
strict gluten-free diet.
Increased risks of venous thrombosis, cardiovascular
disease, and stroke have been demonstrated in adults with
longstanding untreated CD [2–6]. Moreover, a frequent
ﬁnding in CD is hyperhomocysteinemia, which may be
related to the development of vascular disease in CD
patients [2, 7]. Compromised absorptive capacities of
vitamins B6,B 12, and folate in untreated patients make
them susceptible to homocysteine abnormalities [1, 8].
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transfers to various biochemical targets. 5,10-Methylene-
tetrahydrofolate reductase (MTHFR, EC 1.5.1.20) is one of
the critical folate-metabolizing enzymes [9]. It was shown
that subjects homozygous for the c677C[T (rs1801133)
polymorphism of the MTHFR gene (MIM 607093) had
signiﬁcantly elevated total homocysteine concentrations,
whereas the total homocysteine concentration in the CC
subjects did not vary signiﬁcantly from that in the CT
subjects [10]. Genome-wide association study (GWAS) of
determinants of plasma homocysteine level showed that the
MTHFR c.677C[T is the most signiﬁcant gene variant
[11]. Reduced MTHFR activity could alter the distribution
of folate derivatives and the TT genotype is usually asso-
ciated with a 10–30% reduction in circulating folate [12].
Either 5-methyltetrahydrofolate, betaine or S-methylme-
thionine can supply methyl groups for remethylation
of homocysteine to methionine. These reactions are cata-
lyzed by vitamin B12-dependent 5-methyltetrahydrofolate-
homocysteine methyltransferase (MTR, EC 2.1.1.13),
betaine-homocysteine methytransferase 1 and 2 (BHMT1,
EC 2.1.1.5; BHMT2, EC 2.1.1.5), respectively. Cystathio-
nine b-synthase (CBS, EC 4.2.1.22) is involved in the
vitamin B6-dependent transsulfuration pathway, which
converts homocysteine to cystathionine, a substrate for
cysteine synthesis [9]. The methylenetetrahydrofolate
dehydrogenase gene (MTHFD1, MIM 172460) encodes a
trifunctional enzyme, which catalyses the sequential
interconversion of tetrahydrofolate. Methionine synthase
reductase (MTRR, EC 2.1.1.135) is involved in the
regeneration of methylcobalamin, a cofactor for MTR. The
polymorphic variant rs1801198 of the gene for the tran-
scobalamin II protein (TCN2, MIM 613441) has been
reported to potentially interfere with the intracellular
availability of vitamin B12 [13].
In the prospective study of 40 newly-diagnosed celiac
patients and 126 control subjects, Saibeni et al. [8]
observed that folate and vitamin B12 levels were indepen-
dently and inversely associated with homocysteine levels,
and homozygosity for the MTHFR c.677C[T polymor-
phism tended to reach statistical signiﬁcance as a risk
factor. Abnormalities of homocysteine levels in CD do not
consistently improve with a gluten-free diet [14, 15]. It is
noteworthy that the small study by Wilcox and Mattia [14]
revealed a possible excessive expression of the MTHFR
c.677C[T gene variant in CD patients. Moreover, it is
intriguing that despite the high frequency of folate deﬁ-
ciency in untreated celiac patients [16], the suspected
association between maternal CD and an increased risk of
nonsyndromic structural malformations in CD patient off-
spring has received no support from large studies focused
on unfavourable outcomes of pregnancy in untreated CD
women [17, 18]. The suspected association was considered
to be a consequence of hyperhomocysteinemia due to
folate deﬁciency [19–21].
Recently, despite negative clinical observations in
untreated CD women, Arakeri et al. [22] postulated a
relationship between cleft lip and palate and parental CD,
which may be a result of disturbed methylation. Interest-
ingly, there are studies revealing that genetic factors are
related to unfavourable pregnancy outcomes in maternal
CD, but not the degree of clinical severity of CD [23].
Nuclear magnetic resonance (NMR)-based metabonomics
have demonstrated a characteristic signature related to
methyl group metabolism for CD [24]. Polymorphic vari-
ants of genes involved in methyl group metabolism may
modify the susceptibility of carriers to hyperhomocystein-
emia and to having children with potentially folate/coba-
lamin-responsive congenital malformations [9].
Therefore, we hypothesized the existence of differences
between CD patients and the general population in the
distribution of polymorphic variants of genes involved in
homocysteine metabolism. Using case–control study-based
data, we investigated 10 polymorphic variants in 8 genes
involved in methyl group homeostasis, which were previ-
ously tested by our group as maternal genetic risk factors
for orofacial clefts in the Polish population [25, 26].
Materials and methods
Study population
Peripheral blood samples from 134 patients with celiac
disease (age range 2–30 years, the male-to-female ratio
was 0.52) were obtained from two Polish referral centers
for CD (Collegium Medicum of Nicolaus Copernicus
University, Bydgoszcz and Institute of Mother and Child,
Warsaw). All affected individuals were diagnosed
according to the revised ESPGHAN criteria showing a
Marsh III lesion (duodenal villous atrophy with intraepi-
thelial lymphocytosis) and positive tests for anti-endo-
mysium antibodies [1]. In addition, 160 healthy blood
donors were used as controls. Frozen whole blood samples
for DNA isolation were only available and therefore the
participants were not tested for homocysteine and vitamin
B levels. All participants were Caucasian of Polish origin.
Written informed consent was obtained from all individu-
als before enrolment in the study. The study was approved
by the local Ethics Committee.
Single nucleotide polymorphism selection
and genotyping
10 selected single nucleotide polymorphisms (SNPs), with
the exception of TCN2 rs1801198, had been previously
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123tested by us as maternal risk factors for orofacial clefts in
the Polish population [25, 26], and are listed in Table 1.
This set of SNPs was chosen based on the following cri-
teria: HapMap validation status, functional relevance and
importance, and a minor allele frequency (MAF) of[0.05
in the Caucasian population.
DNA was isolated from peripheral blood lymphocytes
by salt extraction. Genotyping of all but three polymor-
phisms was carried out by polymerase chain reaction
(PCR), followed by digestion with the appropriate restric-
tion enzyme (PCR-RFLP) and agarose-gel electrophoresis
(performed according to the manufacturer’s instructions,
Fermentas, Vilnius, Lithuania). BHMT1 (MIM602888)
rs3733890, BHMT2 (MIM 605932) rs625879, and MTRR
(MIM602568) rs1801394 were genotyped by high-resolu-
tion melting curve analysis (HRM) on the LightCycler 480
system (Roche Diagnostics, Mannheim, Germany; http://
www.gene-quantiﬁcation.de/hrm.html). The HRM analysis
results were conﬁrmed by DNA sequencing using ABI
Prism BigDye Terminator Cycle Sequencing kit and an
ABI Prism 3739 capillary sequencer (Applied Biosystems,
Foster City, CA, USA). Samples that failed the genotyping
assays were excluded from statistical analyses. Details of
SNPs selected for genotyping, and the methods of their
analysis, are presented in Table 2.
Statistical analysis
For each marker, MAF, and Chi-square test for Hardy–
Weinberg equilibrium (HWE) were computed in CD
patients and in controls. The differences in allele and
genotype frequencies between cases and controls were
determined using standard Chi-square and Fisher exact
tests. Statistical power was evaluated by Power and Sample
Size Calculation program (http://medipe.psu.ac.th/episoft/
pssamplesize/), Supplementary Table 1. Associations
between the investigated polymorphisms and incidence of
CD were tested using the nonparametric and genetic
model-free Multifactor Dimensionality Reduction (MDR)
approach (MDR version 2.0 beta 5). Statistical signiﬁcance
was evaluated using a 1,000-fold permutation test (MDR
permutation testing module 0.4.9 alpha). The MDR soft-
ware and the MDR permutation testing module are freely
available from http://www.epistasis.org.AP-value of
\0.05 was considered statistically signiﬁcant.
Results
None of the tested SNPs demonstrated deviation from
Hardy-Weinberg equilibrium in either CD patients or
controls. In the patient cases, the MAF for all markers was
at least 4%. The genotype frequencies are summarised in
Table 3. For the analyzed polymorphisms of MTHFR,
MTRR, MTHFD1, CBS (MIM 613381), BHMT1, BHMT2
and TCN2, there was no evidence of a difference in the
allelic and genotypic distribution between celiac patients
and controls. The frequency of the MTR rs1805087 GG
genotype in CD patients was lower than in controls (0.01
and 0.06, respectively), although statistical signiﬁcance
Table 1 Characteristics of the polymorphisms genotyped in the data set
Gene symbol Gene name rs no. SNP
function
a
Protein
effect
Location
b Alleles
c MAF
d
BHMT1 Betaine-homocysteine methyltransferase rs7356530 Intergenic – chr5:78400908 A/g 0.44
rs3733890 Missense Gln239Arg chr5:78421959 a/G 0.28
BHMT2 Betaine-homocysteine methyltransferase 2 rs526264 Intron – chr5:78378410 a/T 0.43
rs625879 Intron – chr5:78381689 G/t 0.43
CBS Cystathionine-beta-synthase 844ins68 –
e – chr21:44483195 W/ins
f 0.06
MTHFD1 Methylenetetrahydrofolate dehydrogenase 1 rs2236225 Missense Arg653Gln chr14:64908845 C/t 0.44
MTHFR 5,10-Methylenetetrahydrofolate reductase rs1801133 Missense Ala222Val chr1:11856378 C/t 0.32
MTR 5-Methyltetrahydrofolate-homocysteine
methyltransferase
rs1805087 Missense Asp919Gly chr1:237048500 A/g 0.25
MTRR Methionine synthase reductase rs1801394 Missense Met22Ile chr5:7870973 A/g 0.45
TCN2 Transcobalamin II rs1801198 Missense Arg259Pro chr22:31011610 C/g 0.44
a According to the Single Nucleotide Polymorphism database (dbSNP)
b Based on UCSC Human Genome Browser, February 2009 human reference sequence (GRCh37)
c Uppercase denotes the more frequent allele in the control samples
d MAF, minor allele frequency calculated from the control samples
e 844ins68 is a 68 bp insertion in exon 8 of CBS
f W, wild allele; ins, allele with insertion
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123was not achieved. The difference between the combined
rs1805087 GG ? AG genotype frequencies in cases and
controls also did not reach signiﬁcance (P = 0.0842). The
statistical power of presented study amounted to 50% for
the MTR rs1805087 GG or AA genotype.
The results of the exhaustive MDR analysis are sum-
marised in Table 4. No combination of possibly interactive
polymorphisms reached statistical signiﬁcance in predict-
ing the incidence of CD.
Discussion
The present investigation was undertaken to identify
potential differences in the distribution of polymorphic
variants of genes encoding key proteins of homocysteine
metabolism between CD patients and the general popula-
tion. Hyperhomocysteinemia, which is frequently due to
deﬁciency of B vitamins and is usually, but inconsistently,
rapidly corrected by a gluten-free diet in CD, might repre-
sent a link between undiagnosed CD and some of its com-
plications [2, 7]. However, we observed no differences
between CD patients and controls in the prevalence of the
common c.677C[T polymorphism of the MTHFR gene, the
most important genetic determinant of blood homocysteine
concentration in the general population [9, 11]. Our results
regarding the distribution of the MTHFR c.677C[T poly-
morphism conﬁrm of the results of Dickey et al. [27] and
Hadithi et al. [15], who also reported a lack of differences
between CD patients and controls in the prevalence of the
MTHFR c.677C[T polymorphism. It is worth mentioning
that there was also no difference in the distribution of the
T-allele between CD women with at least two pregnancy
losses within the ﬁrst 3 months of pregnancy and CD
women with at least one normal pregnancy and no historyof
spontaneous abortions [23]. In contrast to the suggestions of
Wilcox and Mattia (2006), it appears that there is no rele-
vant role in the predisposition of CD patients to hype-
rhomocysteinemia and pregnancy complications due to a
difference in the distribution of MTHFR c.677C[T among
celiac patients and the general population.
MTR rs1805087 polymorphism analysis showed a bor-
derline difference between the polymorphism’s distribution
in celiac patients and controls. Although the results
regarding the rs1805087 polymorphism’s distribution
require conﬁrmation in larger studies, they also warrant
some comments here. MTR is required by cells for the
essential accumulation of folate [28]. The role of the MTR
Table 2 Conditions for the identiﬁcation of methyl group metabolism gene polymorphisms
Gene
symbol
rs no. Primers for PCR ampliﬁcation (50–30) Annealing
temperature
(C)
PCR
product
length (bp)
Restriction
enzyme
Alleles
a Restriction fragment length (bp)
Genotype
[1][1]
b
Genotype
[2][2]
b
BHMT1 rs7356530 F: GCTTACCACAAGTGAAATGACG
R: GGAACTACGCAAATAGCCATC
64.5 549 NlaIII A/g 316, 233 316, 121, 112
rs3733890 F: GTTTCTGGTGCATCCCTAAGT
R: TTGCAGTCAGGAGTGTGGTA
64 190 –
c a/G –
c –
c
BHMT2 rs526264 F: TGGCAAAGACAGGGAGTAGC
R: CAGCTTCTTCAACGTGCTCA
66 576 MboI a/T 576 329, 247
rs625879 F: TTCTCCCTTTGTCCAGCAAC
R: TTGAATCTGAGGAGGCCAGA
66 136 –
c G/t –
c –
c
CBS 844ins68 F: GGGTTTCTCATCCTGCCTCT
R: TCGTCCCCCAGTCTACTTTG
64.2 470 – W/ins
d 470 538
MTHFD1 rs2236225 F: TTCTTCTCATTCTTCCTCACACC
R: TCTGCTCCAAATCCTGCTTC
66 416 MspI C/t 255, 161 416
MTHFR rs1801133 F: AGGCTGTGCTGTGCTGTTG
R: CGCTGTGCAAGTTCTGGAC
67 477 HinfI C/t 425, 52 260, 165, 52
MTR rs1805087 F: GTTGGTGAAGGGAGAAGAAATG
R: CTGAAGAATGGGGGTCTGTG
60 583 HaeIII A/g 583 381, 202
MTRR rs1801394 F: CCCCATTTTTCAGTTTCACTGT
R: CACTTCCCAACCAAAATTCTTC
53 228 –
c A/g –
c –
c
TCN2 rs1801198 F: GCATTACAGGTGGGAAAGAGAC
R: CCAGGGATCTCCATTTACTGTC
67.2 525 MvaI C/g 363, 118, 24, 17, 3 481, 24, 17, 3
a Uppercase denotes the more frequent allele in the control samples
b [1], allele 1; [2], allele 2
c Genotyping with the use of high resolution melting curve analysis (HRM)
d W, wild allele; ins, allele with insertion
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123rs1805087 GG genotype in homocysteine homeostasis and
genomic methylation is debatable [25]. Rs1805087 has
been considerably investigated in humans with structural
malformations [29–32]. In our group of celiac patients, the
frequencies of the GG genotype and of the combined
AG ? GG genotype tended to be reduced in comparison to
controls. The rs1805087 polymorphism, which is a poly-
morphic transition c.2756A[G of the MTR gene leading to
Asp919Gly substitution, has been shown to increase a
woman’s risk for giving birth to a child with isolated cleft
lip with or without cleft palate in the Polish population
[25]. With this in mind, the results of the present study
might indicate that Polish CD patients, who carry the G
allele less frequently in comparison to the general popu-
lation, may be less likely to have offspring with structural
malformations than controls. There is only one source in
the literature of the documented delivery of children with
an orofacial cleft by celiac women with increased plasma
homocysteine levels [20]. There is a high prevalence of CD
in family members of previously diagnosed celiac patients
[1]. However, despite a high incidence of both CD and
craniofacial malformations in the general population, there
are only two case reports, to the best our knowledge, of
coexisting CD and an orofacial cleft (probably syndromic
forms) [33, 34]. A literature search and our present
observations do not support the hypothesis, recently pop-
ularized by Arakeri et al. [22], of a link between parental
CD and orofacial clefts of offspring.
We observed no differences in the distribution of poly-
morphic variants of MTRR, MTHFD1, BHMT1, BHMT2,
and TCN2 between celiac patients and controls. The MDR
method has been successfully applied to detecting one-
carbon metabolism’s gene-to-gene interactions for various
diseases [26, 35]. Previous biochemical and metabonomic
studies have linked CD and alternations in methyl group
metabolism [14, 24]. In contrast to these predictions, in our
study the exhaustive MDR analysis revealed no statistically
signiﬁcant interactive effects of the polymorphic variants
of the investigated genes on an individual’s risk of being
affected by CD.
To the best of the authors’ knowledge, with the
exception of studies devoted to the MTHFR 677C[T
polymorphism [8, 14, 15, 23, 27], this is the ﬁrst report on
the frequency of genes encoding key proteins of homo-
cysteine metabolism in celiac patients, and so we are
unable to compare our results with data from other
studies. Although the percentage of the MTR rs1805087
GG genotype is sixfold lower in celiac patients than in
controls, the absolute number of only two homozygotes
among CD patients precludes meaningful statistical
comparisons between cases and controls with regard to
other possible risk factors. The sample size was small and
may strongly inﬂuence the presented results. It will be
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123necessary to carry out related studies in larger sample
sizes. Moreover, our results may underestimate the true
difference in the distribution of the SNPs between celiac
patients and controls, as we did not take into account the
fact that potentially approx. 1% of our reference group
may also have undiagnosed CD [1, 36]. It must be
stressed that the selected polymorphisms represent only a
fraction of the potential variation of the studied genes.
Restriction or exclusion of all animal foods may result
in vitamin B12 deﬁciency, thereby affecting homocysteine
homeostasis. The investigated ethnically homogenous
population is mostly omnivorous. Recent studies of Y
chromosome STR haplotype distribution showed homo-
geneity of paternal lineages in Poland and their distinc-
tiveness from lineages from the neighboring countries [37].
However, weaknesses of our study include the fact that we
did not have data on food and supplements intake, as well
as on plasma homocysteine and vitamin B levels.
In summary, the present ﬁndings revealed no differences
in the distribution of polymorphic variants of genes
encoding the main proteins involved in homocysteine/
methyl group metabolism between Polish CD patients and
controls. The only exception is MTR rs1805087, which
tended to be less frequent in celiac patients in comparison
to the general population. It may be hypothesized that a
lower frequency of rs1805087 in celiac patients may
modify their risk for having offspring with orofacial mal-
formations. The pathophysiology of CD is not yet com-
pletely understood [1]. Whether or not there is an increased
risk for vitamin B-dependent malformations in offspring of
untreated CD women, despite frequent vitamin B deﬁ-
ciencies, remains an unanswered question and requires
further research.
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